All Products
Displaying products by catalog number (0100 - 0199)
| 0100 | 0200 | 0300 | 0400 | 0500 | 0600 | 0700 | 0800 | 0900 | 1000 |
|---|---|---|---|---|---|---|---|---|---|
| 1100 | 1200 | 1300 | 1400 | 1500 | 1600 | 1700 | 1800 | 1900 | 2000 |
| 2100 | 2200 | 2300 | 2400 | 2500 | 2600 | 2700 | 2800 | 2900 | 3000 |
| 3100 | 3200 | 3300 | 3400 | 3500 | 3600 | 3700 | 3800 | 3900 | 4000 |
| 4100 | 4200 | 4300 | 4400 | 4500 | 4600 | 4700 | 4800 |
Cat.No. |
Product Name / Activity |
| 0101 | DL-AP4 Broad spectrum EAA antagonist |
| 0102 | D-AP4 Broad spectrum EAA antagonist |
| 0103 | L-AP4 Selective group III mGlu agonist |
| 0104 | DL-AP7 Specific NMDA antagonist |
| 0105 | DL-AP5 Potent, selective NMDA antagonist |
| 0106 | D-AP5 Potent, selective NMDA antagonist. More active form of DL-AP5 (Cat. No. 0105) |
| 0107 | L-AP5 Potent, selective NMDA antagonist. Less active form of DL-AP5 (Cat. No. 0105) |
| 0109 | (-)-Bicuculline methobromide Water-soluble GABAA antagonist |
| 0111 | Dihydrokainic acid EAAT2 (GLT-1)-selective non-transportable inhibitor of L-glutamate and L-aspartate uptake |
| 0112 | γDGG Broad spectrum glutamate receptor antagonist |
| 0114 | NMDA Selective NMDA agonist |
| 0125 | DL-AP3 Group I mGlu antagonist |
| 0130 | (+)-Bicuculline Potent GABAA antagonist |
| 0131 | (-)-Bicuculline methochloride Water-soluble GABAA antagonist |
| 0162 | S-Sulfo-L-cysteine sodium salt Group I agonist |
| 0164 | D-AP7 Specific NMDA antagonist. More active form of DL-AP7 (Cat. No. 0104) |
| 0169 | (RS)-AMPA Selective AMPA agonist |
| 0173 | (RS)-CPP Potent NMDA antagonist |
| 0178 | Phaclofen Weak, selective GABAB antagonist |
| 0180 | ZAPA sulfate Agonist at 'low affinity' GABAA receptor. More potent than GABA/muscimol |
| 0181 | TACA GABAA agonist. Also GABA-T substrate and GABA uptake inhibitor |
| 0183 | L-(-)-threo-3-Hydroxyaspartic acid Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor |
| 0186 | cis-ACPD Potent NMDA agonist. Also group II mGluR agonist |
| 0187 | (±)-trans-ACPD Group I/group II mGlu agonist |
| 0188 | L-Quisqualic acid AMPA/group I mGlu agonist |
| 0189 | DNQX Selective non-NMDA antagonist |
| 0190 | CNQX Potent AMPA/kainate antagonist |
| 0197 | Homoquinolinic acid Selective, potent NMDA agonist |
Products Alphabetically by Name
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
|---|
[top]
Quick Order
Find multiple products by catalog number
New Product Guide
Highlights over 130 new products added in 2012. Request a copy or view PDF today.
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

